SK Bioscience has joined a new international effort to advance an updated Zaire ebolavirus vaccine, following a funding agreement between the CEPI and Merck & Co.
With $30 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), Merck & Co. | The project, which involves Merck, SK Biosciences, Hilleman Laboratories and CDMO IDT ...
Merck & Co unit MSD and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered on a $30 ...
Healthbeat on MSN
What’s going well: Marburg virus winding down. A cheap malaria defense. The future of antibiotics.
From effective outbreak control to promising new research, a few developments that suggest key parts of the global health system are still functioning well, even under strain. Get the latest in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results